Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ... Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
REFERENCES Rifat S. L., Eastwood M. R., Crapper McLachlan D. R. and Corey P. N. (1990) Effect of exposure 230 of miners to aluminium powder. Lancet 336, 1162–1165. Rippon G. A. and Marder K. S. (2005) Dementia in Parkinson's disease. Adv. Neurol. 96, 95–113. Roberts E. (1986) Alzheimer’s disease may begin in the nose and may be caused by aluminosilicates. Neurobiol. Aging 7, 561–567. Rodrigues R. W., Gomide V. C. and Chadi G. (2001) Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6- hydroxydopamine. Int. J. Neurosci. 109, 91–126. Rodriguez M. C., Obeso J. A. and Olanow C.W. (1998) Subthalamic nucleusmediated excitotoxicity in Parkinson’s disease: a target for neuroprotection. Ann. Neurol. 44, S175– 188. Rodríguez-Díaz M., Abdala P., Barroso-Chinea P., Obeso J. and González-Hernández T. (2001) Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease. Behav. Brain Res. 122, 79–92. Rodriguez M., Barroso-Chinea P., Abdala P., Obeso J. and Gonzalez-Hernandez T. (2001) Dopamine cell degeneration induced by intraventricular administration of 6- hydroxydopamine in the rat: similarities with cell loss in Parkinson’s disease. Exp. Neurol. 169, 163–181. Rodriguez-Pallares J., Parga J. A., Muñoz A., Rey P., Guerra M. J., Labandeira-Garcia J. L. (2007) Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons. J. Neurochem. 103, 145–156. Roedter A., Winkler C., Samii M., Walter G. F., Brandis A. and Nikkhah G. Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways. J. Comp. Neurol. 432, 217–229.
REFERENCES Roider G. and Drasch G. (1999) Concentration of aluminum in human tissues-investigations on an ocupationally non-exposed population in Southern Bavaria (Germany). Trace Elem. Electrolytes 16, 77–86. Roig J. L., Fuentes S., Colomina M. T., Vicens P. and Domingo J. L. (2006) Aluminum, restraint stress and aging: behavioral effects in rats after 1 and 2 years of aluminum exposure. Toxicology 218, 112–124. Rollin H. B., Theodorou P. and Kilroe-Smith T. A. (1993) Changes in the concentration of copper and zinc in body fluids and tissues of rabbits following the inhalation of low concentrations of Al2O3 dust. S. African J. Sci. 89, 246–249. Roskams A. J. and Connor J. R. (1990) Aluminum access to the brain: a role for transferrin and its receptor. Proc. Natl. Acad. Sci. U. S. A. 87, 9024–9027. Ross G. W., Abbott R. D., Petrovitch H., Morens D. M., Grandinetti A., Tung K. H., Tanner C. M., Masaki K. H., Blanchette P. L., Curb J. D., Popper J. S. and White L. R. (2000) Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 283, 2674–2679. Ross G. W., Abbott R. D., Petrovitch H., Tanner C. M., Davis D. G., Nelson J., Markesbery W. R., Hardman J., Masaki K., Launer L. and White L. R. (2006) Association of olfactory dysfunction with incidental Lewy bodies. Mov. Disord. 21, 2062–2067. Roy S. and Wolman L. (1969) Ultrastructural observations in Parkinsonism. J. Pathol. 99, 39–44. Rozas G., López-Martín E., Guerra M. J., Labandeira-García J. L. (1998) The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism. J. Neurosci. Methods. 83, 165–175. Rybicki B. A., Johnson C. C., Peterson E. L., Kortsha G. X. and Gorell J. M. (1999) A family history of Parkinson's disease and its effect on other PD risk factors. Neuroepidemiology 18, 270– 278. 231
- Page 204 and 205: REFERENCES Agil A., Duran R., Barre
- Page 206 and 207: REFERENCES Baquet Z. C., Bickford P
- Page 208 and 209: REFERENCES 184 1,2,3,6-tetrahydropy
- Page 210 and 211: REFERENCES 186 compacta of the subs
- Page 212 and 213: REFERENCES Chung K. K., Dawson V. L
- Page 214 and 215: REFERENCES Davies K. J. (2001) Degr
- Page 216 and 217: REFERENCES Dhillon A. S., Tarbutton
- Page 218 and 219: REFERENCES Ekstrand M. I., Falkenbe
- Page 220 and 221: REFERENCES Fleming S. M., Delville
- Page 222 and 223: REFERENCES Ghribi O., Dewitt D. A.,
- Page 224 and 225: REFERENCES Good P. F., Olanow C. W.
- Page 226 and 227: REFERENCES Hamilton E. I., Miniski
- Page 228 and 229: REFERENCES Hirsch E. C., Brandel J.
- Page 230 and 231: REFERENCES Inden M., Kitamura Y., T
- Page 232 and 233: REFERENCES Johnson V. J. and Sharma
- Page 234 and 235: REFERENCES Kim W. G., Mohney R. P.,
- Page 236 and 237: REFERENCES Kuhn W., Winkel R., Woit
- Page 238 and 239: REFERENCES 214 K.D. and Polymeropou
- Page 240 and 241: REFERENCES Maraganore D. M., Lesnic
- Page 242 and 243: REFERENCES McCord J. M. and Fridovi
- Page 244 and 245: REFERENCES Miu A. C. and Benga O. (
- Page 246 and 247: REFERENCES Nair V. D., McNaught K.,
- Page 248 and 249: REFERENCES Onyango I. G. (2008) Mit
- Page 250 and 251: REFERENCES Perez F. A. and Palmiter
- Page 252 and 253: REFERENCES Przedborski S. and Goldm
- Page 256 and 257: REFERENCES Rymar V. V., Sasseville
- Page 258 and 259: REFERENCES Savory J., Herman M. M.
- Page 260 and 261: REFERENCES Shimizu H., Mori T., Koy
- Page 262 and 263: REFERENCES 238 the generation of hy
- Page 264 and 265: REFERENCES Taylor G. A., Moore P. B
- Page 266 and 267: REFERENCES Um J. W., Stichel-Gunkel
- Page 268 and 269: REFERENCES Vila M. and Przedborski
- Page 270 and 271: REFERENCES Whitehead M. W., Farrar
- Page 272 and 273: REFERENCES Yokel R. A. (2002a) Alum
- Page 274: REFERENCES Zhou W., Zhu M., Wilson
REFERENCES<br />
Roider G. and Drasch G. (1999) Concentration <strong>of</strong> alum<strong>in</strong>um <strong>in</strong> human tissues-<strong>in</strong>vestigations on<br />
an ocupationally non-exposed population <strong>in</strong> Southern Bavaria (Germany). Trace Elem.<br />
Electrolytes 16, 77–86.<br />
Roig J. L., Fuentes S., Colom<strong>in</strong>a M. T., Vicens P. and Dom<strong>in</strong>go J. L. (2006) Alum<strong>in</strong>um, restra<strong>in</strong>t<br />
<strong>stress</strong> and ag<strong>in</strong>g: behavioral effects <strong>in</strong> rats after 1 and 2 years <strong>of</strong> alum<strong>in</strong>um exposure.<br />
Toxicology 218, 112–124.<br />
Roll<strong>in</strong> H. B., Theodorou P. and Kilroe-Smith T. A. (1993) Changes <strong>in</strong> the concentration <strong>of</strong> copper<br />
and z<strong>in</strong>c <strong>in</strong> body fluids and tissues <strong>of</strong> rabbits follow<strong>in</strong>g the <strong>in</strong>halation <strong>of</strong> low concentrations<br />
<strong>of</strong> Al2O3 dust. S. African J. Sci. 89, 246–249.<br />
Roskams A. J. and Connor J. R. (1990) Alum<strong>in</strong>um access to the bra<strong>in</strong>: a role for transferr<strong>in</strong> and<br />
its receptor. Proc. Natl. Acad. Sci. U. S. A. 87, 9024–9027.<br />
Ross G. W., Abbott R. D., Petrovitch H., Morens D. M., Grand<strong>in</strong>etti A., Tung K. H., Tanner C. M.,<br />
Masaki K. H., Blanchette P. L., Curb J. D., Popper J. S. and White L. R. (2000) Association <strong>of</strong><br />
c<strong>of</strong>fee and caffe<strong>in</strong>e <strong>in</strong>take with the risk <strong>of</strong> Park<strong>in</strong>son disease. JAMA 283, 2674–2679.<br />
Ross G. W., Abbott R. D., Petrovitch H., Tanner C. M., Davis D. G., Nelson J., Markesbery W. R.,<br />
Hardman J., Masaki K., Launer L. and White L. R. (2006) Association <strong>of</strong> olfactory<br />
dysfunction with <strong>in</strong>cidental Lewy bodies. Mov. Disord. 21, 2062–2067.<br />
Roy S. and Wolman L. (1969) Ultrastructural observations <strong>in</strong> Park<strong>in</strong>sonism. J. Pathol. 99, 39–44.<br />
Rozas G., López-Martín E., Guerra M. J., Labandeira-García J. L. (1998) The overall rod<br />
performance test <strong>in</strong> the MPTP-treated-mouse model <strong>of</strong> Park<strong>in</strong>sonism. J. Neurosci.<br />
Methods. 83, 165–175.<br />
Rybicki B. A., Johnson C. C., Peterson E. L., Kortsha G. X. and Gorell J. M. (1999) A family history<br />
<strong>of</strong> Park<strong>in</strong>son's disease and its effect on other PD risk factors. Neuroepidemiology 18, 270–<br />
278.<br />
231